The Future Of Pharmacovigilance: Integrating AI With Drug Safety Systems

By Archana Hegde, Senior Director, PV Systems and Innovations, Lifecycle Safety, and Updesh Dosanjh, Commercialization Lead Safety AI

The pharmaceutical industry is on the cusp of a technological revolution, driven by the rapid integration of artificial intelligence (AI) into pharmacovigilance (PV) systems. As PV teams grapple with an unprecedented surge in data volume and complexity, AI has emerged as a critical tool, capable of transforming case processing, signal detection, and data analysis. While the promise of enhanced speed, efficiency, and patient safety is undeniable, the journey to successful AI implementation in PV workflows requires the strategic navigation of regulatory complexities and meticulous implementation.

To successfully integrate AI, your team will need to align stakeholders, technology, and processes, while supporting all of the above with a robust governance framework. Regulators like the FDA are actively shaping this landscape, providing guidance and fostering collaborative discussions to ensure AI's responsible and effective deployment. Download the full article to dive into the transformative potential of AI in PV while exploring key regulatory considerations and practical strategies for building next-generation drug safety systems.